Advancing New Treatments for Neural Disease
Awarded Intellectual Property
- US Patent #9402875 “Amidated Dopamine Neuron Stimulating Peptide Restoration of Mitochondrial Activity.”
- US Patent #9586992 “Amidated dopamine neuron stimulating peptides for CNS dopaminergic upregulations”
- 3 US and PCT Patent Applications pending.
Our Novel Pipeline
- Peptides that exhibit in vivo activity similar to large proteins.
- Screens have identified biologically active leads
- Selected candidates have demonstrated an intranasal CNS distribution in rats & NHPs and target activation
- Platform for future generations of modification, other disease targets
- All 4,000+ unique molecules have filed patent protection (composition, manufacturing, method of use)